MLAB · Mesa Laboratories Inc · Investor Relations
$131.32
+2.07 (+1.60%)
At close · Oct 28
View the 10-K filed Jun 3, 2026
Return incl. dividend (before tax)
Q1 2027 earnings call transcript
Customer concentration
— top customer 20% of revenue
One customer — 20% of revenue (fiscal 2026)
“In our Clinical Genomics division, a significant portion of revenues is generated from ongoing purchases by a relatively small number of established customers, with a single customer accounting for approximately 20% of the division's revenues in fiscal 2026.”
Market Cap
$723.27M
Shares
5.60M
Volume · Oct 28
143.45K
Avg daily vol (3M)
129.91K
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Recent news
Past events
| Date | Event | Type |
|---|---|---|
| 2026-08-10 | Q1 Earnings conference call (announced in 8-K) | Earnings call |
| 2026-01-15 | 44th Annual J.P. Morgan Healthcare Conference | Conference |
| 2026-01-14 | 44th Annual J.P. Morgan Healthcare Conference | Conference |
| 2025-11-20 | Jeffries Global Healthcare Conference in London | Conference |
| 2021-08-27 | Annual Shareholders’ Meeting | Shareholder meeting |
Source: https://investors.mesalabs.com/
Key facts
CIK
724004
CUSIP
59064R109
13F (30d)
25 filings
25 filers
Visit website
Investor relations